Skolkovo resident Infectex has created a brand new drug against tuberculosis
Biotechnology company Infectex (resident of the Skolkovo Foundation Biomed Cluster, a portfolio company of Maxwell Biotech Venture Fund) has announced positive ...
Tuberculosis
